These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20823707)

  • 21. TGFbeta mediated transition of corneal fibroblasts from a proinflammatory state to a profibrotic state through modulation of histone acetylation.
    Zhou Q; Yang L; Wang Y; Qu M; Chen P; Wang Y; Xie L; Zhao J; Wang Y
    J Cell Physiol; 2010 Jul; 224(1):135-43. PubMed ID: 20232294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in corneal fibroblasts during corneal wound healing.
    Izumi K; Kurosaka D; Iwata T; Oguchi Y; Tanaka Y; Mashima Y; Tsubota K
    Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):591-8. PubMed ID: 16431955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Yin and yang in cytokine regulation of corneal wound healing: roles of TNF-alpha.
    Saika S
    Cornea; 2007 Oct; 26(9 Suppl 1):S70-4. PubMed ID: 17881920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of transforming growth factor-beta isoforms, TGF-beta receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix.
    Tseng SC; Li DQ; Ma X
    J Cell Physiol; 1999 Jun; 179(3):325-35. PubMed ID: 10228951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of melanoma inhibitory activity on transforming growth factor-beta signaling in malignant melanoma.
    Rothhammer T; Bosserhoff AK
    Melanoma Res; 2006 Aug; 16(4):309-16. PubMed ID: 16845326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis.
    Inagaki Y; Okazaki I
    Gut; 2007 Feb; 56(2):284-92. PubMed ID: 17303605
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of 5'TG3'-interacting factors (TGIFs) in Vorinostat (HDAC inhibitor)-mediated Corneal Fibrosis Inhibition.
    Sharma A; Sinha NR; Siddiqui S; Mohan RR
    Mol Vis; 2015; 21():974-84. PubMed ID: 26330748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis.
    Shu DY; Lovicu FJ
    Prog Retin Eye Res; 2017 Sep; 60():44-65. PubMed ID: 28807717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelial mesenchymal transition: a therapeutic target in retrocorneal membrane.
    Miyamoto T; Sumioka T; Saika S
    Cornea; 2010 Nov; 29 Suppl 1():S52-6. PubMed ID: 20935543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Normal corneal wound healing].
    Simion M; Selaru D
    Oftalmologia; 2011; 55(3):12-21. PubMed ID: 22428288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGF beta in fibroproliferative diseases in the eye.
    Saika S; Yamanaka O; Okada Y; Tanaka S; Miyamoto T; Sumioka T; Kitano A; Shirai K; Ikeda K
    Front Biosci (Schol Ed); 2009 Jun; 1(1):376-90. PubMed ID: 19482708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Regeneration and fibrosis of corneal tissues].
    Simirskiĭ VN
    Ontogenez; 2014; 45(5):314-25. PubMed ID: 25752148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TGFβ signaling and the control of myofibroblast differentiation: Implications for chronic inflammatory disorders.
    Carthy JM
    J Cell Physiol; 2018 Jan; 233(1):98-106. PubMed ID: 28247933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decorin biology, expression, function and therapy in the cornea.
    Mohan RR; Tovey JC; Gupta R; Sharma A; Tandon A
    Curr Mol Med; 2011 Mar; 11(2):110-28. PubMed ID: 21342131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of transforming growth factor Beta in corneal function, biology and pathology.
    Tandon A; Tovey JC; Sharma A; Gupta R; Mohan RR
    Curr Mol Med; 2010 Aug; 10(6):565-78. PubMed ID: 20642439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epithelial-mesenchymal transition as a therapeutic target for prevention of ocular tissue fibrosis.
    Saika S; Yamanaka O; Flanders KC; Okada Y; Miyamoto T; Sumioka T; Shirai K; Kitano A; Miyazaki K; Tanaka S; Ikeda K
    Endocr Metab Immune Disord Drug Targets; 2008 Mar; 8(1):69-76. PubMed ID: 18393925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of tumor necrosis factor alpha potentiates transforming growth factor beta-mediated pathogenic tissue response during wound healing.
    Saika S; Ikeda K; Yamanaka O; Flanders KC; Okada Y; Miyamoto T; Kitano A; Ooshima A; Nakajima Y; Ohnishi Y; Kao WW
    Am J Pathol; 2006 Jun; 168(6):1848-60. PubMed ID: 16723700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The myofibroblast, biological activities and roles in eye repair and fibrosis. A focus on healing mechanisms in avascular cornea.
    Rocher M; Robert PY; Desmoulière A
    Eye (Lond); 2020 Feb; 34(2):232-240. PubMed ID: 31767967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Corneal wound healing-Pathophysiology and principles].
    Brockmann T; Walckling M; Brockmann C; Fuchsluger TMA; Pleyer U
    Ophthalmologe; 2021 Nov; 118(11):1167-1177. PubMed ID: 34106316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How the cornea heals: cornea-specific repair mechanisms affecting surgical outcomes.
    Fini ME; Stramer BM
    Cornea; 2005 Nov; 24(8 Suppl):S2-S11. PubMed ID: 16227819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.